NCT04051632

Analysis of Glycemic Control in Type 1 Diabetes Patients Using Hybrid Closed Loop Insulin Pump Therapy (Medtronic 670G)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 96 (actual)
• Sponsor: Boston Children's Hospital · Academic / Other
• Sex: All
• Age: 5 Years – 25 Years
• Healthy volunteers: —

Summary

Observational study of patients at Boston Childrens Hospital with type 1 diabetes (T1D) who elected to treat their diabetes with the Medtronic 670 G hybrid closed loop insulin pump.

Detailed description

Outcome study of 90-100 patients with type 1 diabetes who elected to use the Medtronic 670G. Major outcome measure was to assess the percent of patients who were able to successfully continue to use the 670G technology over time. Additional outcome variables included hemoglobin A1c pre and post treatment with the 670G, time in desired glucose range 70-180.

Conditions

• Biomedical Technology
• Type 1 Diabetes

Interventions

Type	Name	Description
DEVICE	Medtronic 670G insulin pump	* percent of patients who continue to use Medtronic 670G over time * impact of 670G on glycemic control: hemoglobin A1c, time in range

Timeline

• Start date: 2018-06-13
• Primary completion: 2019-07-30
• Completion: 2019-07-30
• First posted: 2019-08-09
• Last updated: 2019-08-09

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study